A review of recent research and development on GLP-1 receptor agonists-sustained-release microspheres-Reference-Cited by-同舟云学术

A review of recent research and development on GLP-1 receptor agonists-sustained-release microspheres

Published:2023 Issue:47 Volume:11 Page:11184-11197
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Gao Zejing¹²³,Wei Yi¹²^ORCID,Ma Guanghui¹²³^ORCID

Affiliation:

1. State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P. R. China

2. Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, P. R. China

3. School of Chemical Engineering, University of the Chinese Academy of Sciences, Beijing 100049, P. R. China

Abstract

This review provides key points in the development of glucagon-like peptide-1 receptor agonist-loaded microspheres from three aspects: preparation methods, strategies to maintain peptide bioactivity, and control the drug release from microspheres.

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2023/TB/D3TB02207B

Reference108 articles.

1. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

2. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

3. Diagnosis and Classification of Diabetes Mellitus

4. The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future

5. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide GLP-1 receptor agonists: From injection to oral delivery strategies;Biochemical Pharmacology;2024-11

2. Potassium voltage-gated channel subfamily H member 2 (KCNH2) is a promising target for incretin secretagogue therapies;Signal Transduction and Targeted Therapy;2024-08-12

3. Development of 1 Month Sustained-Release Microspheres Containing Liraglutide for Type 2 Diabetes Treatment;ACS Applied Materials & Interfaces;2024-05-10